Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
BrightGene Bio Medical Technology C
688166Current price
31.22 CNY
-1.88 CNY (-5.68%)
Last closed
33.56 CNY
Company
www.bright-gene.com
ISIN
CNE100003PR1
Sector
Healthcare
Industry
Biotechnology
Exchange
Shanghai Stock Exchange
Capitalization
14 477 934 372 CNY
Yield for 12 month
-7.63 %
1Y
3Y
5Y
10Y
15Y
688166
BrightGene Bio-Medical Technology Co., Ltd., a pharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products in China. The company offers Eribulin mesylate injection, Voriconazole for injection, Entecavir tablets, Oseltamivir phosphate capsule and dry suspension, Agatroban injection, Mikafungin sodium for injection, Fondaparinux sodium injection, and Caspofungin acetate for injection. It also provides antitumor, antibodies drug conjugate, anti-infection, angiography, gynecology, cardiovascular, cerebrovascular, iron supplement, digestion, and other APIs and intermediates. In addition, the company offers veterinary drugs. BrightGene Bio-Medical Technology Co., Ltd. was founded in 2001 and is based in Suzhou, China. Address: Building C25-28, Suzhou, China, 215123
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
319.75 CNYP/E ratio
75.9333Dividend Yield
–Current Year
+1 182 968 710 CNY
Last Year
+1 020 308 122 CNY
Current Quarter
+318 484 447 CNY
Last Quarter
+341 128 348 CNY
Current Year
+660 029 105 CNY
Last Year
+642 908 374 CNY
Current Quarter
+169 727 537 CNY
Last Quarter
+195 007 988 CNY
Key Figures 688166
1 year
3 years
5 years
10 years
EBITDA
265 373 798 CNY
Operating Margin TTM
PE Ratio
75.9333
Return On Assets TTM
2.27 %
PEG Ratio
–
Return On Equity TTM
6 %
Wall Street Target Price
319.75 CNY
Revenue TTM
1 245 097 776 CNY
Book Value
5.59 CNY
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-2.5 %
Dividend Yield
–
Gross Profit TTM
628 216 740 CNY
Earnings per share
0.45 CNY
Diluted Eps TTM
0.45 CNY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-9.5 %
Profit Margin
15.15 %
Dividend Analytics 688166
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
20 %Dividend History 688166
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
04.07.2024
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
21.33 %
Last Split Date
–
Dividend Date
–
Stock Valuation 688166
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
75.9333
Forward PE
–
Enterprise Value Revenue
11.7412
Price Sales TTM
11.628
Enterprise Value EBITDA
69.5443
Price Book MRQ
5.4937
Financials 688166
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 688166
For 52 weeks
19.69 CNY
41.51 CNY
50 Day MA
28.69 CNY
Shares Short Prior Month
–
200 Day MA
30.1 CNY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart